Ben Potter advises private and public companies, venture capital, and private equity firms, as well as investment banks involved in the technology, life sciences, and other growth industries. He serves as Global Vice Chair of the Emerging Companies Practice and Co-Chair of the Technology Industry Group.
Mr. Potter provides clients timely hands-on support and leverages access to the full resources of the firm’s global platform. He draws on considerable legal insight and complementary prior experience at IBM Global Services and two education startup companies in New York City.
Mr. Potter provides clients with company representation on a full range of matters and transactions, including:
- Public and private financing transactions
- Mergers and acquisitions
- Formation issues
- Employment matters
- Equity incentives
- Securities law compliance
- License agreements
- Corporate governance matters
Mr. Potter’s representative clients include:
Technology
- Alpine Roads
- Area 1 Security
- Baotris
- Bright Machines
- Dolls Kill
- Duolingo
- Impossible Foods
- Joby Aviation
- Light
- LiquidSpace
- Memebox
- Mosaic
- Nozomi Networks
- Shift Technologies
- Solvvy
- Synack
- Zanbato
Life Sciences and Medical Devices
- 4D Molecular Therapeutics
- Afferent Pharmaceuticals
- Alios Biopharma
- Antiva BioSciences
- Attenua
- Calysta Energy
- Coherus BioSciences
- Crossover Health
- Curasen Therapeutics
- Envoy Therapeutics
- FerroKin BioSciences
- Genascence
- Ideaya
- Imago BioSciences
- MAP Pharmaceuticals
- Pendulum Therapeutics
- Pionyr
- Plexxikon
- Tizona Therapeutics
Venture Capital and Private Equity
- 8VC
- a16z
- Eclipse
- Formation 8
- General Catalyst
- Gurnet Point Capital
- KKR
- Kleiner Perkins Caufield & Byers
- Meritech Capital Partners
- Paradigm
- Sequoia